Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Diabetes Care · 1997 · 6.2K citations

Medicine, Endocrinology, Internal Medicine +11

Patterns and Mechanisms of In-Stent Restenosis

Rainer Hoffmann, Gary S. Mintz, G Dussaillant et al. · Circulation · 1996 · 1.3K citations

Medicine, Cardiology, Interventional Cardiology +16

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Taku Yamamoto, Takamichi Nakamura, Nancy A. Noble et al. · Proceedings of the National Academy of Sciences · 1993 · 829 citations

Medicine, Nephrology, Pathology +16

Influence of Diabetes Mellitus on Early and Late Outcome After Percutaneous Transluminal Coronary Angioplasty

Bernardo Stein, William S. Weintraub, Suzanne S P Gebhart et al. · Circulation · 1995 · 533 citations

Medicine, Cardiology, Internal Medicine +15

Potent Inhibitory Effect of Troglitazone on Carotid Arterial Wall Thickness in Type 2 Diabetes

J Minamikawa, Satsuki Tanaka, Mika Yamauchi et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 453 citations

Medicine, Endocrinology, Pharmacology +17